Try our Advanced Search for more refined results

Expert Analysis

How Big Pharma Has Responded To FTC Delisting Demands

By Ratib Ali and Celia Lu ( August 15, 2025, 7:14 PM EDT) -- The Federal Trade Commission under former Chair Lina Khan expressed concerns about high prescription drug prices and believed that improper patent protection was partly responsible for it. Under Chair Andrew Ferguson, the FTC maintains the same concerns and continues to address improper patent protection....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies